Whitepaper
Modernizing clinical evidence beyond trials and registries
Generating high-quality clinical evidence has never been more urgent. As healthcare costs rise and patient needs grow, the industry demands faster approaches to assess the safety and effectiveness of drugs, devices, and treatments. Traditional clinical trials are costly, time-consuming, and often limited in generalizability. Truveta Data offers a scalable, scientifically rigorous complement, enabling researchers to reduce reliance on clinical trials and registries using real-time intelligence from over 130 million patients.
This whitepaper provides insight into:
- The limitations of clinical trials and how real-world data can generate faster, more contemporary clinical intelligence.
- Why Truveta Data offers a more complete and timely alternative to registries, claims-derived datasets, and other real-world data sources.
- How Truveta Data compares to randomized controlled trials and registry results using published examples.
- How Truveta Data supports post-market studies and synthetic control arms as part of modern evidence generation strategies.
